Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd.; (Pharmaceuticals); Manati, Puerto Rico

On May 13, 2019, Bristol-Myers Squibb Holdings Pharma, Ltd. submitted a notification of proposed production activity to the FTZ Board for its facility within FTZ 7, in Manati, Puerto Rico.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (84 FR 23759—23760, May 23, 2019). On September 10, 2019, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.